Daniel Rea

University of Birmingham
Cancer Research UK Clinical Trials Unit (CRCTU)
Vincent Drive
Edgbaston
Birmingham
B15 2TT
United Kingdom

Email: d.w.rea@bham.ac.uk
Tel: 0121 414 5345
Web: Lab website

A Cancer Research (UK) randomized phase II study of idoxifene in patients with locally advanced/metastatic breast cancer resistant to tamoxifen

Cancer Chemother Pharmacol.2004;53 :341-348

Epirubicin and cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy for early breast cancer

N Engl J Med.2006;355 :1851-1862

Recent publications